23andMe
Matt Kvarda joined 23andMe as Chief Restructuring Officer in March 2025 to help oversee the Company’s voluntary Chapter 11 proceedings. Matt is a Managing Director at Alvarez & Marsal with over 30 years of restructuring experience and has served in interim management roles at numerous companies, including as interim Chief Financial Officer at Revlon (NYSE: REV), TEAM, Inc. (NYSE: TEAM) and Jacuzzi Brands. Matt brings valuable expertise in advising companies through complex restructurings and will lead the oversight and management of 23andMe’s restructuring and sale process. Matt holds a B.A. in Economics from the University of California at San Diego and an MBA from the University of California at Los Angeles. He is a Certified Insolvency and Restructuring Advisor (CIRA), with distinction, and a member of the Association of Insolvency and Restructuring Advisors (AIRA).
This person is not in any teams
This person is not in any offices
23andMe
87 followers
23andMe is on a mission-driven company with big dreams of using data to revolutionize health, wellness and research. They want to improve healthcare. They want to prevent disease. They want to give individuals control over their health data. They want to dramatically accelerate the pace of research. They want to develop better drugs smarter and faster. There is no comfort zone. They do not shy away from controversy, and they never give up. They are pioneering a new world, centered on the consumer, where success depends on bold ideas and unprecedented scale. Big is key, and thinking big drives them.